Pharmaceutical

STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud

STAT+: Pharmalittle: Bristol Myers to buy schizophrenia...

Dec 23, 2023

Bristol Myers agreed to pay $14 billion for Karuna Therapeutics, which has an ex...

STAT+: Bristol Myers to purchase Karuna, maker of schizophrenia drug, for $14 billion

STAT+: Bristol Myers to purchase Karuna, maker of schiz...

Dec 23, 2023

Bristol Myers Squibb said Friday that it will acquire Karuna Therapeutics, a dev...

Opinion: The unique pain and joy of celebrating Christmas with a child in the pediatric intensive care unit

Opinion: The unique pain and joy of celebrating Christm...

Dec 23, 2023

“Every Christmas since my daughter died, I have tried to run away from those mem...

STAT+: AAFP’s CEO on how to keep primary care doctors in the field

STAT+: AAFP’s CEO on how to keep primary care doctors i...

Dec 23, 2023

“Family medicine and primary care's obituary has been written many times in my 2...

3 issues to watch in global health in 2024

3 issues to watch in global health in 2024

Dec 23, 2023

In the world of infectious diseases and global health, if it’s not one thing, it...

STAT+: FDA approves AstraZeneca, Ionis treatment for rare nerve disease

STAT+: FDA approves AstraZeneca, Ionis treatment for ra...

Dec 23, 2023

The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...

Cadonilimab by Akeso for Esophageal Squamous Cell Carci...

Dec 22, 2023

Cadonilimab is under clinical development by Akeso and currently in Phase II for...

SOR-007 by Nanology for Metastatic Adenocarcinoma of Th...

Dec 22, 2023

SOR-007 is under clinical development by Nanology and currently in Phase II for ...

MRNA-2752 by Moderna for Transitional Cell Cancer (Urot...

Dec 22, 2023

MRNA-2752 is under clinical development by Moderna and currently in Phase I for ...

Imvotamab by IGM Biosciences for Rheumatoid Arthritis: ...

Dec 22, 2023

Imvotamab is under clinical development by IGM Biosciences and currently in Phas...

XB-002 by Exelixis for Breast Cancer: Likelihood of App...

Dec 22, 2023

XB-002 is under clinical development by Exelixis and currently in Phase II for B...

Iruplinalkib by Qilu Pharmaceutical for Solid Tumor: Li...

Dec 22, 2023

Iruplinalkib is under clinical development by Qilu Pharmaceutical and currently ...

Runimotamab by Genentech USA for Solid Tumor: Likelihoo...

Dec 22, 2023

Runimotamab is under clinical development by Genentech USA and currently in Phas...

IDE-161 by Ideaya Biosciences for Metastatic Ovarian Ca...

Dec 22, 2023

IDE-161 is under clinical development by Ideaya Biosciences and currently in Pha...

Volrustomig by AstraZeneca for Cervical Cancer: Likelih...

Dec 22, 2023

Volrustomig is under clinical development by AstraZeneca and currently in Phase ...

IBI-322 by Innovent Biologics for Lymphoma: Likelihood ...

Dec 22, 2023

IBI-322 is under clinical development by Innovent Biologics and currently in Pha...